Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Resolution Synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112321613B reveals a novel route for high-purity Edoxaban Tosylate and isomers. Discover cost-effective manufacturing strategies for this critical anticoagulant API.
Patent CN108586517B details a cost-effective route for 4-AA using chiral resolution, offering reliable supply and reduced heavy metal contamination for API manufacturers.
Patent CN102363599A reveals a robust chiral resolution method for sitagliptin intermediates using D-di-p-toluoyl tartrate, offering significant cost reduction and scalable manufacturing for pharmaceutical supply chains.
Patent CN1305460A reveals a novel resolution process using L-pyroglutamic acid for high-purity tetrahydrocarbazole intermediates, offering significant cost and supply chain advantages.
Patent CN101003549B discloses a robust synthesis of planar chiral [2.2]paracyclophane phosphines via cyclopalladium resolution, offering high stability for pharmaceutical intermediates.
Patent CN113480521B details a novel synthesis route for Bepotastine Besilate offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing partners seeking scalable solutions.
Patent CN106632368A reveals a scalable total synthesis route for Irinotecan Hydrochloride, ensuring high purity and supply chain stability for global API manufacturers.
Patent CN100427460C details a scalable L-norvaline synthesis from n-valeric acid, offering cost reduction in API manufacturing and high-purity chiral intermediates.
Patent CN104418784B details a novel resolution method for antiviral intermediates. Achieve high de% purity and scalable manufacturing for pharmaceutical supply chains.
Novel 5-step synthesis for L-serine offers high yield and purity. Ideal for reliable pharmaceutical intermediate supplier partnerships and cost reduction.
Novel resolution method ensures high purity acetate salt stability for scalable API manufacturing and significant cost reduction in production.
Novel low-cost route for Sitagliptin intermediates via chiral resolution. Reduces catalyst costs and simplifies scale-up for API manufacturing.
Patent CN104496843B details a low-cost ubenimex synthesis route avoiding toxic resolving agents, offering significant supply chain and purity advantages for pharmaceutical manufacturers.
Patent CN103435532A details a low-cost synthesis of Boceprevir intermediates. Discover how this novel route eliminates precious metal catalysts for superior supply chain reliability.
Patent CN102399139B details a scalable resolution method for Shikonin and Alkannin. Achieve >99% ee with cost-effective raw materials for API manufacturing.
Patent CN109553610A details a novel six-step synthesis for emtricitabine isomers offering high purity and scalable manufacturing processes for global supply chains.
Patent CN105820113A details a robust chiral resolution method for Crizotinib intermediates. This process ensures high purity, operational simplicity, and substantial cost reduction in pharmaceutical manufacturing.
Advanced synthesis of Barnidipine Hydrochloride via chiral resolution. High purity, scalable route for API manufacturing. Cost-effective solution for hypertension drugs.
Novel chiral resolution method using aspartic acid eliminates chromatography, offering high purity and scalable production for pharmaceutical intermediates.
Solve complex synthesis challenges with this 5-step chiral resolution method. Eliminate corrosive reagents, reduce equipment costs, and ensure 99%+ purity for your pharmaceutical intermediates.